RHA Redensity®

The first and only FDA-approved HA filler for injection into both the superficial dermis and dermis to treat dynamic perioral rhytids1

TEOXANE RHA 4

BEFORE

AFTER

Results that last up to 12 months*1

Patient’s lips and oral commissures were treated with 0.9 mL of RHA®3, and her lipstick lines were improved with 1.2 mL of RHA Redensity®. Images captured before and two weeks after treatment. Results may vary.

May be appropriate for patients who desire:

  • Correction with a superficially placed filler in the dermis
  • A natural look and feel without unwanted heaviness1-3

*Clinical effectiveness and safety were demonstrated in a 12-month clinical trial for the treatment of moderate to severe perioral rhytids.1,2

Explore more results

RHA Redensity®

Indicated for injection into the dermis and superficial dermis of the face, in adults aged 22 or older.1